UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

Hepatology (Baltimore, Md.), 2015-11, Vol.62 (5), p.1353-1363

2015

Volltextzugriff (PDF)

Access to treatment for hepatitis C virus infection: time to put patients first

The Lancet infectious diseases, 2016-09, Vol.16 (9), p.e196-e201

Edlin, Brian R, Dr

2016

Volltextzugriff (PDF)

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

Annals of internal medicine, 2013-02, Vol.158 (4), p.235

2013

Volltextzugriff (PDF)

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention

PloS one, 2017-05, Vol.12 (5), p.e0177341-e0177341

2017

Volltextzugriff (PDF)

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease

Health technology assessment (Winchester, England), 2011-02, Vol.15 (6), p.1-244

2011

Volltextzugriff (PDF)

Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users

Clinical infectious diseases, 2005-04, Vol.40 (Supplement-5), p.S276-S285

2005

Volltextzugriff (PDF)

Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users

Clinical infectious diseases, 2004-11, Vol.39 (10), p.1540-1543

2004

Volltextzugriff (PDF)

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment‐naïve patients

Hepatology (Baltimore, Md.), 2008-12, Vol.48 (6), p.1769-1778

2008

Volltextzugriff (PDF)

High Prevalence of Abscesses and Cellulitis Among Community-Recruited Injection Drug Users in San Francisco

Clinical infectious diseases, 2000-03, Vol.30 (3), p.579-581

2000

Volltextzugriff (PDF)

Risk Factors for Skin and Soft-Tissue Abscesses among Injection Drug Users: A Case-Control Study

Clinical infectious diseases, 2001-07, Vol.33 (1), p.35-40

2001

Volltextzugriff (PDF)

Perspective: Test and treat this silent killer

Nature (London), 2011-05, Vol.474 (7350), p.s18-s19

Edlin, Brian R.

2011

Volltextzugriff (PDF)

Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016

Hepatology (Baltimore, Md.), 2019-03, Vol.69 (3), p.1020-1031

2019

Volltextzugriff (PDF)

Test and treat this silent killer

Nature (London), 2011-06, Vol.474 (7350), p.S18-S19

Edlin, Brian R

2011

Volltextzugriff (PDF)

The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study

PloS one, 2017-09, Vol.12 (9), p.e0181004-e0181004

2017

Volltextzugriff (PDF)

Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis

The Lancet (British edition), 2001-05, Vol.357 (9266), p.1397-1401

2001

Volltextzugriff (PDF)

A cluster randomised controlled trial of a web based decision aid to support parents’ decisions about their child's Measles Mumps and Rubella (MMR) vaccination

Vaccine, 2013-12, Vol.31 (50), p.6003-6010

2013

Volltextzugriff (PDF)

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial

JAMA internal medicine, 2022-05, Vol.182 (5), p.494

2022

Volltextzugriff (PDF)

Injection Drug Users: The Overlooked Core of the Hepatitis C Epidemic

Clinical infectious diseases, 2006-03, Vol.42 (5), p.673-676

2006

Volltextzugriff (PDF)

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

Nature genetics, 2013-02, Vol.45 (2), p.164-171

2013

Volltextzugriff (PDF)

Predictors and Prevention of Nonfatal Overdose Among Street-Recruited Injection Heroin Users in the San Francisco Bay Area, 1998-1999

American journal of public health (1971), 2001-11, Vol.91 (11), p.1842-1846

2001

Volltextzugriff (PDF)

Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach

PLoS medicine, 2006-10, Vol.3 (10), p.e452

2006

Volltextzugriff (PDF)

Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

Journal of Clinical Microbiology, 2008-02, Vol.46 (2), p.499-506

2008

Volltextzugriff (PDF)

Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion

The Journal of infectious diseases, 2012-03, Vol.205 (5), p.763-771

2012

Volltextzugriff (PDF)

Hepatitis C Virus (HCV)-Specific Immune Responses of Long-Term Injection Drug Users Frequently Exposed to HCV

The Journal of infectious diseases, 2008-07, Vol.198 (2), p.203-212

2008

Volltextzugriff (PDF)

Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes

PloS one, 2015-10, Vol.10 (10), p.e0138827-e0138827

2015

Volltextzugriff (PDF)

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(232)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

Access to treatment for hepatitis C virus infection: time to put patients first

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease

Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users

Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment‐naïve patients

High Prevalence of Abscesses and Cellulitis Among Community-Recruited Injection Drug Users in San Francisco

Risk Factors for Skin and Soft-Tissue Abscesses among Injection Drug Users: A Case-Control Study

Perspective: Test and treat this silent killer

Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016

Test and treat this silent killer

The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study

Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis

A cluster randomised controlled trial of a web based decision aid to support parents’ decisions about their child's Measles Mumps and Rubella (MMR) vaccination

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial

Injection Drug Users: The Overlooked Core of the Hepatitis C Epidemic

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

Predictors and Prevention of Nonfatal Overdose Among Street-Recruited Injection Heroin Users in the San Francisco Bay Area, 1998-1999

Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach

Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion

Hepatitis C Virus (HCV)-Specific Immune Responses of Long-Term Injection Drug Users Frequently Exposed to HCV

Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes

Suchergebnisse filtern